BGLAF (BioGaia AB) Net Change in Cash: $-20.6 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BGLAF BioGaia AB BGLAF
99 GF Score
Price $11.55
GF Value $13.20
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is BioGaia AB Net Change in Cash?

BioGaia AB BGLAF 99 Net Change in Cash is $-20.6 Mil as of Jun. 2026. GuruFocus rates BGLAF with a GF Score™ of 99/100 and a GF Value™ of $13.20 (Modestly Undervalued). The stock has 1 warning sign investors should review.

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

BioGaia AB's Net Change in Cash for the three months ended in Jun. 2026 was $-45.6 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Jun. 2026 was $-20.6 Mil.

BioGaia AB Net Change in Cash Historical Data

* Premium members only.

The historical data trend for BioGaia AB's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BioGaia AB Net Change in Cash Chart

BioGaia AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Net Change in Cash
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.96 0.36 5.26 -30.29 -43.10

BioGaia AB Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Net Change in Cash Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -64.61 10.14 7.17 7.71 -45.62
BGLAF
99GF Score
BioGaia AB BGLAF
Net Change in Cash is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BioGaia AB Net Change in Cash Calculation

BioGaia AB's Net Change in Cash for the fiscal year that ended in Dec. 2025 is calculated as

Net Change in Cash= Cash Flow from Operations+Cash Flow from Investing+Cash Flow from Financing+Effect of Exchange Rate Changes
=31.25829429934+-0.34086127568841+-72.379949503172+-1.6344619351736
=-43.1

BioGaia AB's Net Change in Cash for the quarter that ended in Jun. 2026

Net Change in Cash=Cash Flow from Operations+Cash Flow from Investing+Cash Flow from Financing+Effect of Exchange Rate Changes
=5.2374039123361+-1.3347330008789+-49.747697479789+0.22183283696535
=-45.6

Net Change in Cash for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-20.6 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Change in Cash →
What does a Net Change in Cash of $-20.6 Mil mean?
BioGaia AB (BGLAF) has a Net Change in Cash of $-20.6 Mil as of Jun. 2026. The net change in cash is the total change in cash and equivalents between the current period and the past period. View historical data for BioGaia AB and its competitors.
Is BioGaia AB's Net Change in Cash too high?
BioGaia AB's current Net Change in Cash is $-20.6 Mil. Overall, BioGaia AB has a GF Score™ of 99/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does BioGaia AB's Net Change in Cash compare to ZTS?
BioGaia AB's Net Change in Cash of $-20.6 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Change in Cash for a Drug Manufacturers company?
A good Net Change in Cash depends on the Drug Manufacturers industry context. However, Net Change in Cash should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Change in Cash mean?
A high Net Change in Cash can signal that a stock is expensive relative to its fundamentals. The net change in cash is the total change in cash and equivalents between the current period and the past period. View historical data for BioGaia AB and its competitors. BioGaia AB's current Net Change in Cash is $-20.6 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BioGaia AB stock overvalued right now?
Based on GuruFocus' analysis, BioGaia AB (BGLAF) is currently considered Modestly Undervalued. The stock's GF Value™ is $13.20, compared to a current price of $11.55 — trading 12.5% below its estimated fair value. The current Net Change in Cash is $-20.6 Mil. BioGaia AB's overall GF Score™ is 99/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Change in Cash calculated?
Net Change in Cash is calculated from a company's financial statements. For BioGaia AB (BGLAF), the current Net Change in Cash is $-20.6 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is BioGaia AB (BGLAF) Overvalued in 2026?

Based on GuruFocus' analysis, BioGaia AB stock appears to be undervalued. The current stock price of $11.55 is trading 12.5% below its estimated GF Value™ of $13.20. GuruFocus considers BioGaia AB to be Modestly Undervalued.

Key valuation signals for BGLAF:

  • Net Change in Cash: $-20.6 Mil
  • GF Value™: $13.20 vs. price of $11.55 (12.5% below fair value)
  • GF Score™: 99/100 with 1 warning sign

No single metric tells the full story. See the BGLAF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

BioGaia AB Business Description

Address Kungsbroplan 3A, Stockholm, SWE, SE-112 27
BioGaia AB is a healthcare company engaged in developing, marketing, and selling probiotic products. The company has three operating segments; Paediatrics segment includes drops, gut health tablets, oral rehydration solution (ORS) and cultures to be used as ingredients in licensee products such as infant formula, as well as royalty revenue for pediatric products, Adult Health segment includes gut health tablets, oral health lozenges and cultures as an ingredient in a licensee's dairy products, and Other segment include royalties in respect of development projects, revenue from packaging solutions in the subsidiary CapAble, etc. Geographically, it operates in three regions: EMEA, the Americas, and APAC (Asia-Pacific, Australia, and New Zealand).
99GF Score

Get the complete analysis for BGLAF

Net Change in Cash is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$11.55
Price
$13.20
GF Value